Apiam Animal Health (ASX:AHX) Research & Development: A$0.0 Mil (TTM As of Jun. 2025)


ASX:AHX Apiam Animal Health Ltd ASX:AHX
50 GF Score
Price A$0.88
GF Value A$0.40
! 9 Warning Signs
View Full Analysis

What is Apiam Animal Health Research & Development?

Apiam Animal Health ASX:AHX 50 Research & Development is A$0.0 Mil as of Jun. 2025. GuruFocus rates ASX:AHX with a GF Score™ of 50/100 and a GF Value™ of A$0.40. The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Apiam Animal Health's Research & Development for the six months ended in Jun. 2025 was A$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was A$0.0 Mil.

Apiam Animal Health  (ASX:AHX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Apiam Animal Health Research & Development Related Terms

Apiam Animal Health Research & Development Historical Data

* Premium members only.

The historical data trend for Apiam Animal Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apiam Animal Health Research & Development Chart

Apiam Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Apiam Animal Health Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:AHX
50GF Score
Apiam Animal Health Ltd ASX:AHX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apiam Animal Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.0 Mil mean?
Apiam Animal Health (ASX:AHX) has a Research & Development of A$0.0 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Apiam Animal Health and its competitors.
Is Apiam Animal Health's Research & Development too high?
Apiam Animal Health's current Research & Development is A$0.0 Mil. Overall, Apiam Animal Health has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Apiam Animal Health's Research & Development compare to ROL and SCI?
Apiam Animal Health's Research & Development of A$0.0 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Personal Services company?
A good Research & Development depends on the Personal Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Apiam Animal Health and its competitors. Apiam Animal Health's current Research & Development is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apiam Animal Health stock overvalued right now?
Apiam Animal Health (ASX:AHX) has a current Research & Development of A$0.0 Mil. The stock's GF Value™ is A$0.40, compared to a current price of A$0.88 — trading 118.8% above its estimated fair value. The current Research & Development is A$0.0 Mil. Apiam Animal Health's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Apiam Animal Health (ASX:AHX), the current Research & Development is A$0.0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apiam Animal Health (ASX:AHX) Overvalued in 2026?

Based on GuruFocus' analysis, Apiam Animal Health stock appears to be overvalued. The current stock price of A$0.88 is trading 118.8% above its estimated GF Value™ of A$0.40.

Key valuation signals for ASX:AHX:

  • Research & Development: A$0.0 Mil
  • GF Value™: A$0.40 vs. price of A$0.88 (118.8% above fair value)
  • GF Score™: 50/100 with 9 warning signs

No single metric tells the full story. See the ASX:AHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apiam Animal Health Business Description

Address 27- 33 Piper Lane, East Bendigo, Bendigo, VIC, AUS, 3550
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
50GF Score

Get the complete analysis for ASX:AHX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.88
Price
A$0.40
GF Value